INDUSTRY ACADEMIC COOPERATION FOUNDATION; HALLYM UNIVERSITY
发明人:
CHOI, SU YOUNGKR,최수영,PARK, JIN SEOKR,박진서,KIM, DAE WONKR,김대원,PARK, YOUNG ZAKR,박영자,YOO, DONG HWANKR,유동환
申请号：
KR1020120125966
公开号：
KR1020140059472A
申请日:
2012.11.08
申请国别(地区):
KR
年份:
2014
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising a natural pozzolan as a main ingredient for preventing and treating atopy dermatitis and which can be used as a pharmaceutical composition like an external skin application having an excellent atopy dermatitis alleviation effect by suppressing NK-kB expression and cytokine expression. The pharmaceutical composition of the present invention shows effects of far-infrared and negative ion emissions, NK-kB inhibition, cytokine expression inhibition, and alleviation of atopic skin inflammation.COPYRIGHT KIPO 2014본 발명은 천연 포졸란을 주성분으로 하는 아토피 피부염 예방 및 치료용 약학 조성물로서, NK-kB 발현 및 싸이토카인 발현 억제 결과를 나타내서 아토피 피부 염증 개선 효과가 우수하여 피부외용제 등의 약학 조성물로 이용할 수 있다.
